Alnylam Pharmaceuticals (ALNY) Q2 2026 Earnings

Apr 30Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.54
0.25
1.05
1.84

Details

Expected EPS
0.8715
Actual EPS
1.51
Surprise EPS
0.64
Surprise Percent
+73.26%

Description

⁨Alnylam Pharmaceuticals⁩ (⁦ALNY⁩) has reported earnings of ⁦1.51⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts